Agilon Health, Inc.
General ticker "AGL" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $507.6M (TTM average)
Agilon Health, Inc. follows the US Stock Market performance with the rate: 52.2%.
Estimated limits based on current volatility of 2.4%: low 84.93$, high 89.14$
Factors to consider:
- Total employees count: 856 (-20.4%) as of 2025
- Top business risk factors: History of losses, Failure to grow geographies, Operational and conduct risks, Inability to secure MA payor contracts, Inability to raise capital
- Current price 176.1% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [9.81$, 32.06$]
- 2026-12-31 to 2027-12-31 estimated range: [7.34$, 23.25$]
Financial Metrics affecting the AGL estimates:
- Negative: with PPE of -0.7 at the end of fiscal year the price was very high
- Negative: negative Operating cash flow
- Negative: negative Net income
- Negative: 7.04 < Shareholder equity ratio, % of 9.97 <= 12.78
- Negative: -0.37 < Inventory ratio change, % of 0
- Negative: Industry operating cash flow per share per price (median), % of 4.90 <= 5.56
- Negative: Industry operating profit margin (median), % of -0.34 <= 0.59
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term AGL quotes
Long-term AGL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $4,316.36MM | $6,060.53MM | $5,932.58MM |
| Operating Expenses | $4,548.50MM | $6,352.66MM | $6,395.81MM |
| Operating Income | $-232.13MM | $-292.13MM | $-463.24MM |
| Non-Operating Income | $37.67MM | $43.30MM | $59.14MM |
| Interest Expense | $6.66MM | $6.18MM | $6.64MM |
| Income(Loss) | $-194.46MM | $-248.83MM | $-404.10MM |
| Taxes | $0.79MM | $1.45MM | $1.25MM |
| Other Income(Loss) | $-67.55MM | $-9.82MM | $14.00MM |
| Net Income(Loss)* | $-262.60MM | $-260.15MM | $-391.35MM |
| Stockholders Equity | $661.84MM | $470.95MM | $126.73MM |
| Assets | $1,740.87MM | $1,733.98MM | $1,271.29MM |
| Operating Cash Flow | $-156.20MM | $-57.78MM | $-105.76MM |
| Capital expenditure | $30.82MM | $13.25MM | $13.24MM |
| Investing Cash Flow | $-44.02MM | $139.89MM | $88.61MM |
| Financing Cash Flow | $-193.13MM | $-2.58MM | $-2.99MM |
| Earnings Per Share** | $-16.05 | $-15.83 | $-23.63 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.